Diagnostic Value of Protein Ki67 (MIB-1) in Atypical Pap Smears of Postmenopausal Women

被引:7
|
作者
Fakhrjou, Ashraf [1 ]
Dastranj-Tabrizi, Ali [1 ]
Ghojazadeh, Morteza [2 ]
Ghorashi, Sona [5 ]
Velayati, Atefeh [6 ]
Piri, Reza [3 ]
Vahedi, Amir [1 ]
Sayyah-Melli, Manizhe [2 ]
Smaeili, Heydar-Ali [1 ]
Bonakdari, Amir [1 ]
Halimi, Monireh [1 ]
Naghavi-Behzad, Mohammad [4 ]
机构
[1] Tabriz Univ Med Sci, Dept Pathol, Tabriz, Iran
[2] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Iran
[4] Tabriz Univ Med Sci, Med Philosophy & Hist Res Ctr, Tabriz, Iran
[5] Islamic Azad Univ, Young Researchers Club, Tabriz, Iran
[6] Islamic Azad Univ, Dept Midwifery, Tabriz Branch, Tabriz, Iran
关键词
Vaginal smears; Ki-67; antigen; postmenopause; negative predictive potential; CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN PAPILLOMA-VIRUS; KI-67; KNOWLEDGE; PREVALENCE; EXPRESSION; P16/KI-67; INFECTION; EFFICACY; CYTOLOGY;
D O I
10.7314/APJCP.2013.14.8.4815
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Atrophic epithelium of cervix sampled from postmenopausal women may mimic high-grade cervical intraepithelial neoplasia in Papanicolaou-stained (Pap) smears. Ki-67 (MIB-1) protein presents on proliferating cells, and percentage of cells with positive nuclei provides a reliable tool for rapid evaluation of the growth fraction. The aim of this study was to determine the diagnostic value of protein Ki67 staining in atypical pap smears of postmenopausal women. Methods: In a case-control setting, pap smears of 75 women with an atypical pap smear (case group) and 75 with normal pap smears (controls) were obtained before and after estrogen treatment. Afterward, samples were exposed to the monoclonal antibody Ki-67 (MIB-1) and the immunohistochemically demonstrated Ki-67+ cells were compared. Results: Mean ages of cases and controls were 60.4 +/- 4.5 and 59.9 +/- 4.3 years respectively (P=0.50). There was one (2.7%) positive Ki-67 specimen in the case group, without any positive Ki-67 specimen in the control group (P=0.50). Conclusions: Measurement of proliferative activity index in Pap smears restrained with MIB1 is a simple, reliable, and cost-effective method for excluding negatives. This would imply that it might allow a substantial reduction of diagnostic estrogen courses and subsequent Pap smears in postmenopausal women with atypical findings.
引用
收藏
页码:4815 / 4818
页数:4
相关论文
共 50 条
  • [21] The use of Ki-67/MIB-1 immunostaining in human gliomas
    Torp, S. H.
    Mork, J. N.
    Torp, M. O.
    Skjulsvik, A. J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 : 53 - 53
  • [22] Ki-67/MIB-1 immunostaining in a cohort of human gliomas
    Skjulsvik, Anne J.
    Mork, Jorgen N.
    Torp, Morten O.
    Torp, Sverre H.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 8905 - 8910
  • [23] Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis
    Li, Junhong
    Liang, Ruofei
    Song, Chen
    Xiang, Yufan
    Liu, Yanhui
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2019, 29 (02): : 140 - 149
  • [24] Immunohistochemical study of Ki-67 (MIB-1), p53 protein, ER and FIR expression in benign and atypical meningiomas
    Anga, A.
    Lowery, C. N.
    Jackson, J.
    Fowler, M.
    Vannemreddy, P.
    Lowery-Nordberg, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 660 - 660
  • [25] MIB-1 and PCNA immunostaining as a diagnostic adjunct to cervical pap smear
    Goel, MM
    Mehrotra, A
    Singh, U
    Gupta, HP
    Misra, JS
    DIAGNOSTIC CYTOPATHOLOGY, 2005, 33 (01) : 15 - 19
  • [26] Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 Labeling index is a predictor for recurrence of adrenocortical carcinomas
    Morimoto, Ryo
    Satoh, Fumitoshi
    Murakami, Osamu
    Suzuki, Takashi
    Abe, Takaaki
    Tanemoto, Masayuki
    Abe, Mlchiaki
    Uruno, Akira
    Ishidoya, Shigeto
    Arai, Yoichi
    Takahashi, Kazuhiro
    Sasano, Hironobu
    Ito, Sadayoshi
    ENDOCRINE JOURNAL, 2008, 55 (01) : 49 - 55
  • [28] MIB-1, KI67, AND PCNA SCORES AND DNA FLOW-CYTOMETRY IN INTERMEDIATE GRADE MALIGNANT-LYMPHOMAS
    PICH, A
    PONTI, R
    VALENTE, G
    CHIUSA, L
    GEUNA, M
    NOVERO, D
    PALESTRO, G
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (01) : 18 - 22
  • [29] MIB-1 (Ki-67) labeling indices in 261 consecutive gliomas
    Prok, AL
    Prayson, RA
    Barnett, GH
    MODERN PATHOLOGY, 2002, 15 (01) : 301A - 301A
  • [30] Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas
    Devaprasath, A
    Chacko, G
    NEUROLOGY INDIA, 2003, 51 (03) : 336 - 340